Abstract: An apparatus for decoding an encoded audio signal to obtain a reconstructed audio signal is provided, having: a receiving interface for receiving one or more frames, a coefficient generator, and a signal reconstructor. The coefficient generator is configured to determine one or more first audio signal coefficients, and one or more noise coefficients. Moreover, the coefficient generator is configured to generate one or more second audio signal coefficients, depending on the one or more first audio signal coefficients and depending on the one or more noise coefficients.

Abstract: The invention relates to a foamable bead polymer consisting of (meth)acrylonitrile, (meth)acrylic acid, copolymerizable latent blowing agents and optionally (meth)acrylic esters, the preparation thereof by suspension polymerization and the use thereof for producing foams. Such a bead polymer makes it possible, for example, to carry out in-mould foaming in a simple way and thus produce products having the shape of the desired workpiece directly. These workpieces are highly suitable as components in space, air, water and land vehicles and for other construction elements.

Abstract: An encoder for predictively encoding a signal having a sequence of signal values has a predictor for performing an adaptive prediction in dependence on the signal, and in dependence on one or more weighting values, to obtain predicted signal values, wherein the predictor is configured to reset the weighting values at times which are dependent on the signal, and wherein the predictor is configured to adapt the weighting values to the signal between subsequent resets.

Abstract: A device for producing a frequency-shifted audio signal based on an audio input signal is provided. The device has an interface and a frequency-shifting unit. The interface is configured for receiving the audio input signal. The frequency-shifting unit is configured for producing the frequency-shifted audio signal. The frequency-shifting unit is additionally configured to produce one of the second subband values based on one of the first subband values such that the second phase angle of this second subband value differs from the first phase angle of this first subband value by a phase angle difference, the phase angle difference being dependent on frequency information indicating by which frequency difference the audio input signal is to be shifted in order to obtain the frequency-shifted audio signal, and the phase angle difference being dependent on a frequency bandwidth of one of the first subbands.

Abstract: An apparatus for generating spectral replacement values for an audio signal has a buffer unit for storing previous spectral values relating to a previously received error-free audio frame. Moreover, the apparatus includes a concealment frame generator for generating the spectral replacement values, when a current audio frame has not been received or is erroneous. The previously received error-free audio frame has filter information, the filter information having associated a filter stability value indicating a stability of a prediction filter. The concealment frame generator is adapted to generate the spectral replacement values based on the previous spectral values and based on the filter stability value.

Abstract: An encoder for predictively encoding a signal having a sequence of signal values has a predictor for performing an adaptive prediction in dependence on the signal, and in dependence on one or more weighting values, to obtain predicted signal values, wherein the predictor is configured to reset the weighting values at times which are dependent on the signal, and wherein the predictor is configured to adapt the weighting values to the signal between subsequent resets.

Abstract: The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt.

Abstract: Composition for the production of mouldings having a matt and structured surface character, comprising a polymer matrix and crosslinked polymer particles, the polymer matrix comprising at least one acrylic polymer and the composition containing (i) first crosslinked polymer particles having a volume average of the particle size in the range from 30 ?m to 1500 ?m and (ii) second crosslinked polymer particles having a volume average of the particle size of less than 30 ?m, the difference between the refractive index of the first polymer particles and the refractive index of the polymer matrix, measured in each case at 25° C., being less than 0.015 as an absolute value and the difference between the refractive index of the second polymer particles and the refractive index of the polymer matrix, measured at 25° C., being greater than or equal to 0.015 as an absolute value.

Abstract: Process for preparation of bead polymers whose average particle size is in the range from 1 ?m to 40 ?m, by dispersing and polymerizing a polymerizable composition in an aqueous phase, where the dispersion stabilized by an aluminium compound is prepared at a shear rate ?103 s?1. A polymerizable composition is used here which, in each case based on its total weight, comprises a) more than 50.0% by weight of at least one compound of the formula (I), ?where the radicals 1R to 6R have definitions according to the Description, b) from 0.1% by weight to 10.0% by weight of at least one crosslinking agent and c) less than 49.9% by weight of at least one compound of the formula (II) ?where the radicals R and 7R to 9R have definitions according to the Description The bead polymers prepared according to the inventive process are particularly suitable for production of mouldings with light-scattering properties.

Abstract: Process for preparation of bead polymers whose average particle size is in the range from 1 ?m to 40 ?m, by dispersing and polymerizing a polymerizable composition in an aqueous phase, where the dispersion stabilized by an aluminium compound is prepared at a shear rate ?103 s?1. A polymerizable composition is used here which, in each case based on its total weight, comprises a) more than 50.0% by weight of at least one compound of the formula (I), where the radicals 1R to 6R have definitions according to the Description, b) from 0.1% by weight to 10.0% by weight of at least one crosslinking agent and c) less than 49.9% by weight of at least one compound of the formula (II) where the radicals R and 7R to 9R have definitions according to the Description The bead polymers prepared according to the inventive process are particularly suitable for production of mouldings with light-scattering properties.

Abstract: The invention relates to a dispersion suitable for use as coating agent and binder for pharmaceutical forms, having a solids content of 10–70% by weight consisting of a) from 90 to 99% by weight of a methacrylate copolymer consisting of at least 90% by weight of (meth)acrylate monomers containing neutral radicals and having a glass transition temperature Tg of from ?20° C. to +20° C. as determined by the DSC method, and b) 1–10% by weight of a nonionic emulsifier having an HLB of from 15.2 to 17.3.

Abstract: The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt.

Abstract: The invention relates to a dispersion suitable for use as coating agent and binder for pharmaceutical forms, having a solids content of 10-70% by weight consisting of